Clinical Trials Logo

Clinical Trial Summary

The Study evaluates the role of low dose epinephrine boluses in management of acute hypo-tension VS The Traditional management of acute hypo-tension.

Half of the participants suffering from acute hypo-tension will receive low dose epinephrine boluses (≤ 5 µg/kg/dose) and the other half will receive traditional management of shock


Clinical Trial Description

Epinephrine, due to its alpha-1 and beta-adrenergic effects, is considered an important part of the management of children with hypo-tension. Epinephrine is typically used as a continuous infusion (0.02-0.5 μg/kg/min) for severe sustained hypo-tension and as a bolus (0.01 mg/kg, maximum dose = 1 mg) for bradycardia, asystole, or pulse-less arrest. There are, however, clinical conditions that may benefit from smaller doses of bolus epinephrine. For example, brief periods of hypo-tension during medical procedures, intermittent hemodynamic instability, and augmentation of low blood pressure in a pre-arrest condition. While a resuscitation (or code) dose of epinephrine would be inappropriate (as it would cause an unacceptable large increase in blood pressure and heart rate [HR]), a smaller dose may be particularly useful.

Low-dose bolus vasopressors have been used for decades by anaesthesiologists to prevent post-re-perfusion injury after solid organ transplant, control cerebral oxygenation during anaesthesia and manage acute hypo-tension during spinal surgery. Recently, use of bolus dose phenyl-ephrine has been described in the emergency department setting to augment blood pressure during periods of hypo-tension surrounding intubation. Finally, free open access medical publications have provided some insight into using bolus dose pressors for acute hypotensive episodes in adults. However, there is few published data describing the use of low-dose vasopressor boluses in children. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03671070
Study type Interventional
Source Assiut University
Contact Maher M Ahmed, Professer
Phone +201062052802
Email maher61ahmed@aun.edu.eg
Status Not yet recruiting
Phase N/A
Start date January 1, 2019
Completion date September 1, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT02782819 - A Comparison of Crystalloid Alone Versus Crystalloid Plus Colloid in Shock Resuscitation N/A
Completed NCT06121115 - Norepinephrine Administration Through a Midline Catheter in an Intermediate Care Unit
Terminated NCT04538079 - Non-invasive Objective Assessment of Hemodynamics in Preterm Neonates
Completed NCT03701646 - ClearSight Validation in Pediatrics
Completed NCT02070276 - Predict Fluid Responsiveness in Spinal Anesthesia N/A
Completed NCT04891380 - BCG Biosensor and Non- and Invasive Monitoring During Emergency Medicine Cases, a Prospective Feasibility Study N/A
Completed NCT03927066 - Physiological Validation of Current Machine Learning Models for Hemodynamic Instability in Humans N/A
Recruiting NCT04760977 - Prehospital Management of Hypotensive Trauma in HEMS
Completed NCT03582501 - Measurement of Hemodynamic Responses to Lower Body Negative Pressure N/A
Terminated NCT03407287 - Peripheral Venous Analysis (PIVA) for Predicting Volume Responsiveness and Fluid Status
Active, not recruiting NCT04688450 - BP Management System User Acceptance Testing N/A
Terminated NCT03214809 - The Use of a Point-of-care Thoracic Ultrasound Protocol for Hospital Medical Emergency Teams N/A
Completed NCT04497155 - Prehospital Norepinephrine and Early Mortality in Traumatic Shock
Completed NCT04269382 - Accuracy of Non-Invasive Blood Pressure Measurements at the Arm, Calf , and Finger N/A
Recruiting NCT05931601 - Early Initiated Vasopressor Therapy in the Emergency Department Phase 3
Recruiting NCT05355974 - Using Vasopressor Medication to Support Blood Pressure During Intubation Procedure Phase 3
Completed NCT04529005 - Angiotensin II in the Perioperative Management of Hypotension in Kidney Transplant Recipients Phase 4